520 related articles for article (PubMed ID: 27362483)
1. CRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections.
van Diemen FR; Kruse EM; Hooykaas MJ; Bruggeling CE; Schürch AC; van Ham PM; Imhof SM; Nijhuis M; Wiertz EJ; Lebbink RJ
PLoS Pathog; 2016 Jun; 12(6):e1005701. PubMed ID: 27362483
[TBL] [Abstract][Full Text] [Related]
2. Potential Application of the CRISPR/Cas9 System against Herpesvirus Infections.
Chen YC; Sheng J; Trang P; Liu F
Viruses; 2018 May; 10(6):. PubMed ID: 29844277
[TBL] [Abstract][Full Text] [Related]
3. Development of Genome Editing Approaches against Herpes Simplex Virus Infections.
Zhang I; Hsiao Z; Liu F
Viruses; 2021 Feb; 13(2):. PubMed ID: 33671590
[TBL] [Abstract][Full Text] [Related]
4. RNA-guided gene editing of the murine gammaherpesvirus 68 genome reduces infectious virus production.
Foreman HC; Kirillov V; Paniccia G; Catalano D; Andrunik T; Gupta S; Krug LT; Zhang Y
PLoS One; 2021; 16(6):e0252313. PubMed ID: 34086743
[TBL] [Abstract][Full Text] [Related]
5. [Prevention and therapy of herpesvirus infections].
Abb J
Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9, a powerful tool to target human herpesviruses.
van Diemen FR; Lebbink RJ
Cell Microbiol; 2017 Feb; 19(2):. PubMed ID: 27860066
[TBL] [Abstract][Full Text] [Related]
7. Herpesviral lytic gene functions render the viral genome susceptible to novel editing by CRISPR/Cas9.
Oh HS; Neuhausser WM; Eggan P; Angelova M; Kirchner R; Eggan KC; Knipe DM
Elife; 2019 Dec; 8():. PubMed ID: 31789594
[TBL] [Abstract][Full Text] [Related]
8. Complete and Prolonged Inhibition of Herpes Simplex Virus Type 1 Infection In Vitro by CRISPR/Cas9 and CRISPR/CasX Systems.
Karpov DS; Demidova NA; Kulagin KA; Shuvalova AI; Kovalev MA; Simonov RA; Karpov VL; Snezhkina AV; Kudryavtseva AV; Klimova RR; Kushch AA
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499174
[TBL] [Abstract][Full Text] [Related]
9. Suppression of Epstein-Barr virus DNA load in latently infected nasopharyngeal carcinoma cells by CRISPR/Cas9.
Yuen KS; Wang ZM; Wong NM; Zhang ZQ; Cheng TF; Lui WY; Chan CP; Jin DY
Virus Res; 2018 Jan; 244():296-303. PubMed ID: 28456574
[TBL] [Abstract][Full Text] [Related]
10. Targeted Mutagenesis of Guinea Pig Cytomegalovirus Using CRISPR/Cas9-Mediated Gene Editing.
Bierle CJ; Anderholm KM; Wang JB; McVoy MA; Schleiss MR
J Virol; 2016 Aug; 90(15):6989-6998. PubMed ID: 27226370
[TBL] [Abstract][Full Text] [Related]
11. Targeting human cytomegalovirus IE genes by CRISPR/Cas9 nuclease effectively inhibits viral replication and reactivation.
Xiao J; Deng J; Zhang Q; Ma P; Lv L; Zhang Y; Li C; Zhang Y
Arch Virol; 2020 Aug; 165(8):1827-1835. PubMed ID: 32507978
[TBL] [Abstract][Full Text] [Related]
12. Human cytomegalovirus latent infection alters the expression of cellular and viral microRNA.
Fu M; Gao Y; Zhou Q; Zhang Q; Peng Y; Tian K; Wang J; Zheng X
Gene; 2014 Feb; 536(2):272-8. PubMed ID: 24361963
[TBL] [Abstract][Full Text] [Related]
13. Highly Efficient CRISPR/Cas9-Mediated Cloning and Functional Characterization of Gastric Cancer-Derived Epstein-Barr Virus Strains.
Kanda T; Furuse Y; Oshitani H; Kiyono T
J Virol; 2016 May; 90(9):4383-93. PubMed ID: 26889033
[TBL] [Abstract][Full Text] [Related]
14. Rapid CRISPR/Cas9-Mediated Cloning of Full-Length Epstein-Barr Virus Genomes from Latently Infected Cells.
Yajima M; Ikuta K; Kanda T
Viruses; 2018 Apr; 10(4):. PubMed ID: 29614006
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of HSV-1 Replication by Gene Editing Strategy.
Roehm PC; Shekarabi M; Wollebo HS; Bellizzi A; He L; Salkind J; Khalili K
Sci Rep; 2016 Apr; 6():23146. PubMed ID: 27064617
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells are susceptible to human herpesviruses, but viral DNA cannot be detected in the healthy seropositive individual.
Sundin M; Orvell C; Rasmusson I; Sundberg B; Ringdén O; Le Blanc K
Bone Marrow Transplant; 2006 Jun; 37(11):1051-9. PubMed ID: 16604097
[TBL] [Abstract][Full Text] [Related]
17. Phylogenetic studies of frequently diagnostically sampled herpesviruses--possibilities for clinical applications?
Tang JW
Infect Genet Evol; 2013 Aug; 18():379-86. PubMed ID: 23201040
[TBL] [Abstract][Full Text] [Related]
18. Mutagenesis and Genome Engineering of Epstein-Barr Virus in Cultured Human Cells by CRISPR/Cas9.
Yuen KS; Chan CP; Kok KH; Jin DY
Methods Mol Biol; 2017; 1498():23-31. PubMed ID: 27709566
[TBL] [Abstract][Full Text] [Related]
19. Chromatinisation of herpesvirus genomes.
Paulus C; Nitzsche A; Nevels M
Rev Med Virol; 2010 Jan; 20(1):34-50. PubMed ID: 19890944
[TBL] [Abstract][Full Text] [Related]
20. RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection.
Wang J; Quake SR
Proc Natl Acad Sci U S A; 2014 Sep; 111(36):13157-62. PubMed ID: 25157128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
